Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552822 · ClinicalTrials.gov registry record
Cesarean Section Via Enhanced Recovery
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 541
- Enrollment target
NCT03552822: Completed study, sponsored by University of Alabama at Birmingham.
NCT03552822 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 541 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03552822 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
Study Summary
Enhanced Recovery After Surgery (ERAS) protocols have been proven to be very successful in specific patient populations. An example is with ERAS for colorectal surgery. ERAS protocols in this patient population have been shown to reduce overall morbidity and hospital length of stay (LOS). At the University of Alabama at Birmingham (UAB), the institution has had successful implementation of ERAS protocols for several surgical specialties including colorectal, breast, spine, gynecology, and gynecology-oncology. However, the institution currently does not have a protocol in place for the most commonly performed surgical procedure - cesarean delivery. At UAB, the institution performs approximately 1,000 cesarean deliveries per year. The investigators believe that an ERAS protocol will be beneficial for these patients. Currently, there is very little data published on ERAS protocols. Although this patient population is ideal for an ERAS protocol, there are several barriers that have to be overcome. The data published show promising results for ERAS protocols with cesarean delivery. A larger tertiary care center showed earlier discharge with lower re-admission rates with an ERAS pathway. Currently, the investigators have created a multidisciplinary group at UAB to establish an ERAS protocol for patients undergoing cesarean delivery. This group includes anesthesiologists, obstetricians, nursing, neonatology, pharmacy, and informatics. Once the investigators have implemented this protocol, the investigators would like to perform a retrospective analysis to determine if there are any significant changes in our desired outcomes the investigators will study. Our goal is to demonstrate significantly improved outcomes in the investigators' measured endpoints. The investigators believe that this information will be very useful because although there is a national interest in creating ERAS protocols for cesarean deliveries, there currently is very little published on the subject
Primary Outcome
Measurement of opioid consumption in oral morphine equivalents
Interventions
- OTHER ERAS Protocol Implementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-02-01 |
What the finished NCT03552822 record still lists
NCT03552822 is an observational study that tracks outcomes without assigning an intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ERAS Protocol Implementation is the first listed.
NCT03552822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03552822 about?
NCT03552822 is a clinical study titled "Cesarean Section Via Enhanced Recovery". Enhanced Recovery After Surgery (ERAS) protocols have been proven to be very successful in specific patient populations. An example is with ERAS for colorectal surgery. ERAS protocols in this patient population have been shown to reduce overall morbidity and hospital length of stay (LOS). At the Uni...
What is the current status of trial NCT03552822?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2018-07-01. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT03552822?
The interventions under investigation include: ERAS Protocol Implementation (OTHER).
Who is sponsoring clinical trial NCT03552822?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI